Roadshow
E.V.A. (Ex Vivo Avatar)
E.V.A. combines 3D cell culture scaffolding with AI image recognition to facilitate tumor cell proliferation. Using just 20mL of patient blood, we can grow tumor cells to generate heterogeneous organoid models that closely mimic the patient's internal tumor. These models allow pharmaceutical companies to identify the best candidates for clinical trials by validating the efficacy of their drugs in suppressing tumor cells from real patients.
Join us at BIO 2025, June 16-19 in Boston, where CancerFree Biotech Ltd. will be showcasing our cutting-edge solutions and services. We can't wait to connect with you to discuss how we're shaping the future of biotechnology. Find us at Booth 1645. See you there!
#BIO2025#TAIWAN PAVILION
E.V.A. combines 3D cell culture scaffolding with AI image recognition to facilitate tumor cell proliferation. Using just 20mL of patient blood, we can grow tumor cells to generate heterogeneous organoid models that closely mimic the patient's internal tumor. These models allow pharmaceutical companies to identify the best candidates for clinical trials by validating the efficacy of their drugs in suppressing tumor cells from real patients.
- Established 2018
- Company CancerFree Biotech Ltd.
- Telephone +886-2-2732-2701
- Email kevin@cancerfree.io
- Address 3F.-2, No.56, Ln. 258, Ruiguang Rd., Neihu Dist., Taipei City 114062,Taiwan (R.O.C.)
CancerFree Biotech has developed a proprietary cancer cell culture system called E.V.A. (Ex Vivo Avatar). E.V.A. combines 3D cell culture scaffolding with AI image recognition to facilitate tumor cell proliferation. Using just 20mL of patient blood, we can grow tumor cells to generate heterogeneous organoid models that closely mimic the patient's internal tumor. These models allow pharmaceutical companies to identify the best candidates for clinical trials by validating the efficacy of their drugs in suppressing tumor cells from real patients.